Do you know about - GENETICS Jim Rogers interviews Kári Stefánsson, MD, deCODE
Causes Of Afib ! Again, for I know. Ready to share new things that are useful. You and your friends. What I said. It is not outcome that the real about Causes Of Afib . You check out this article for home elevators an individual need to know is Causes Of Afib .How is GENETICS Jim Rogers interviews Kári Stefánsson, MD, deCODE
GENETICS Jim Rogers interviews Kári Stefánsson, MD, deCODE Video Clips. Duration : 13.42 Mins.We had a good read. For the benefit of yourself. Be sure to read to the end. I want you to get good knowledge from Causes Of Afib . Jim Rogers interviews Kári Stefánsson, MD, Dr.Med. President of deCODE Gene Mapping Company Jim Rogers is an economic expert and author who traveled to over 150 countries Copyright Jim Rogers - provided as a special contribution to The Fenton Report Kári Stefánsson, MD, Dr. Med. has served as our President, Chief Executive Officer and a Director since he co-founded deCODE in August 1996. Dr. Stefánsson was appointed to serve as the Chairman of our Board of Directors in December 1999. From 1993 until April 1997, Dr. Stefánsson was a professor of Neurology, Neuropathology and Neuroscience at Harvard University. In addition, from 1993 through December 1996 he was Director of Neuropathology at Beth Israel Hospital in Boston, Massachusetts. From 1983 to 1993, he held faculty positions in Neurology, Neuropathology and Neurosciences at the University of Chicago. Dr. Stefánsson received his MD and Dr. Med. from the University of Iceland and is board-certified in neurology and neuropathology in the United States. About deCODE genetics Headquartered in Reykjavik, Iceland, deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the ...
